You searched for
We found 9 articles
The ALK Grass Tablet in Subjects with Hayfever

The ALK Grass Tablet in Subjects with Hayfever

This trial is performed to assess the efficacy and safety of the ALK Grass tablet for treatment of grass pollen…

01 Jan 2013

ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

A study of ASP2151 in subjects with recurrent outbreaks of genital herpes. Official Title A Phase II, Dose-Finding Study With…

01 Jan 2013

A Trial of the ALK Grass Tablet in Subjects With Hayfever

A Trial of the ALK Grass Tablet in Subjects With Hayfever

This trial is performed to assess the efficacy and safety of the ALK Grass tablet for treatment of grass pollen…

01 Jan 2013

An Effectiveness and Safety Study of ‘CONCERTA’ (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder

The purpose of this study is to evaluate the safety and effectiveness of CONCERTA (methylphenidate hydrochloride, a central nervous system…

01 Jan 2013

Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma

RATIONALE: Bortezomib may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: This…

01 Jan 2013

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Randomized phase III trial to compare the effectiveness of cisplatin plus gemcitabine with or without paclitaxel in treating patients who…

01 Jan 2013

Intralesional PV-10 Chemoablation of Metastatic Melanoma

Intralesional PV-10 Chemoablation of Metastatic Melanoma

The objective of this study is to investigate the safety of intralesional (IL) PV-10 for the treatment of metastatic melanoma.

01 Jan 2013

Study of “NY-ESO-1 ISCOMATRIX” in Patients With High-Risk, Resected Melanoma

Study of “NY-ESO-1 ISCOMATRIX” in Patients With High-Risk, Resected Melanoma

The purpose of this trial is to assess whether treatment with “NY-ESO-1 ISCOMATRIX” vaccine improves outcomes for people with Malignant…

01 Jan 2013

A Safety Study of Two Intratumour Doses of Coxsackievirus Type A21 in Melanoma Patients.

A Safety Study of Two Intratumour Doses of Coxsackievirus Type A21 in Melanoma Patients.

The purpose of the study is to determine the safety and tolerability of two doses of Coxsackievirus A21, administered 48…

01 Jan 2013